Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $60 Price Target
Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $60 Price Target
Needham再次建議買入Ionis Pharmaceuticals,維持60美元的目標價。
Needham analyst Joseph Stringer reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $60 price target.
Needham分析師Joseph Stringer重申買入納斯達克的Ionis Pharmaceuticals(ION),維持60美元的目標價格。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。